Nucleic acids encoding IKR-2, a protein kinase related to the I kappa B kinases
AssigneeImmunex Corporation
InventorsTimothy A. Bird, G. Duke Virca
Life of this patent
Estimating the term…
Abstract
The invention is directed to purified and isolated kappa B kinase-related kinases 1 and 2 (IKR-1 and IKR-2) polypeptides and fragments thereof, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.
Claims23
An isolated nucleic acid molecule selected from the group consisting of:
- (a) a polynucleotide molecule having the sequence of SEQ ID NO:3;
- (b) a polynucleotide molecule encoding an amino acid sequence comprising the sequence of SEQ ID NO:4;
- and
- (c) a polynucleotide molecule, or its complement, that hybridizes to a denatured DNA molecule comprising the nucleic acid sequence of (a) in 50% formamide and 6×SSC at 42 degrees C., and washing in 0.2×SSC and 0.1% SDS at 68 degrees C., wherein the polynucleotide molecule encodes a polypeptide having kinase activity.
An isolated polynucleotide molecule that encodes a polypeptide having kinase activity and comprising amino acids 1-300 of SEQ ID NO:4.
An isolated polynucleotide molecule encoding a polypeptide having kinase activity, the polynucleotide molecule comprising a nucleotide sequence selected from the group consisting of:
- (a) a nucleotide sequence encoding an amino acid sequence selected from the group consisting of amino acids 1 through 53 of SEQ ID NO:4, amino acids 1 through 300 of SEQ ID NO:4, amino acids 2 through 53 of SEQ ID NO:4, amino acids 143 through 234 of SEQ ID NO:4, amino acids 185 through 234 of SEQ ID NO:4, amino acids 185 through 309 of SEQ ID NO:4, amino acids 310 through 319 of SEQ ID NO:4, amino acids 310 through 414 of SEQ ID NO:4, amino acids 320 through 414 of SEQ ID NO:4, amino acids 320 through 439 of SEQ ID NO:4, amino acids 415 through 439 of SEQ ID NO:4, amino acids 415 through 486 of SEQ ID NO:4, amino acids 440 through 486 of SEQ ID NO:4, amino acids 440 through 598 of SEQ ID NO:4, amino acids 487 through 598 of SEQ ID NO:4, amino acids 487 through 620 of SEQ ID NO:4, amino acids 599 through 620 of SEQ ID NO:4, amino acids 599 through 623 of SEQ ID NO:4, amino acids 624 through 662 of SEQ ID NO:4, amino acids 624 through 673 of SEQ ID NO:4, amino acids 663 through 673 of SEQ ID NO:4, amino acids 663 through 686 of SEQ ID NO:4, amino acids 674 through 686 of SEQ ID NO:4, and amino acids 674 through 690 of SEQ ID NO:4;
- (b) a nucleotide sequence of (a), wherein said nucleotide sequence is a fragment of SEQ ID NO:3;
- (c) the nucleotide sequence of a polynucleotide molecule, or its complement, that hybridizes to a denatured DNA molecule comprising the nucleotide sequence of (b) in 50% formamide and 6×SSC at 42 degrees C., and washing in 0.2×SSC and 0.1% SDS at 68 degrees C., wherein the nucleotide sequence encodes a polypeptide having kinase activity;
- and
- (d) a nucleotide sequence that is at least 90% identical to the nucleotide sequence of (b), wherein the nucleotide sequence encodes a polypeptide having kinase activity.
Dependencies are inferred from the claim text.